NAD+ Supplements: Evidence-Based Guide to NAD Restoration

NAD+ Supplements: The Complete Evidence-Based Guide to NAD+ Restoration

NAD+ supplements are compounds that increase nicotinamide adenine dinucleotide (NAD+) levels in cells, a critical coenzyme involved in energy metabolism, DNA repair, and cellular aging. The most researched NAD+ precursors include nicotinamide mononucleotide (NMN), nicotinamide riboside (NR), and niacin (vitamin B3). NAD+ levels decline approximately 50% between ages 40 and 60, correlating with age-related metabolic dysfunction and disease risk.

The scientific interest in NAD+ restoration accelerated following research from David Sinclair's lab at Harvard Medical School and Charles Brenner at the University of Iowa, demonstrating that raising NAD+ levels in animal models improved mitochondrial function, extended healthspan, and reversed markers of aging. While human clinical trials remain limited, the biological rationale for supplementation has driven significant research investment and clinical application.

What Are NAD+ Supplements?

NAD+ (nicotinamide adenine dinucleotide) functions as an electron carrier in hundreds of metabolic reactions, particularly in the mitochondrial electron transport chain where ATP is generated. Every cell in the human body requires NAD+ to produce energy, repair DNA, regulate circadian rhythms, and maintain cellular health.

Direct NAD+ supplementation is ineffective because the molecule is too large to cross cell membranes efficiently. Instead, NAD+ supplements provide biosynthetic precursors—smaller molecules that cells convert into NAD+ through established metabolic pathways. The primary precursor pathways include:

Preiss-Handler pathway: Converts niacin (nicotinic acid) to NAD+
Salvage pathway: Recycles nicotinamide (NAM) back to NAD+ via nicotinamide phosphoribosyltransferase (NAMPT)
NR pathway: Converts nicotinamide riboside through NR kinases (NRK1/NRK2)
NMN pathway: Direct conversion via proposed NMN transporters or extracellular conversion

Practitioner-grade brands available through Apotheca's longevity collection include Thorne, Pure Encapsulations, ProHealth Longevity, and Vita Aid—companies that maintain third-party testing protocols and pharmaceutical manufacturing standards.

Why NAD+ Levels Decline With Age

Multiple mechanisms contribute to the age-related decline in NAD+ bioavailability:

Increased NAD+ Consumption

Poly(ADP-ribose) polymerases (PARPs) and sirtuins, two enzyme families critical for DNA repair and cellular stress response, consume NAD+ as a substrate. As DNA damage accumulates with age, PARP activation increases, depleting NAD+ pools. Research published in Cell Metabolism (2016) by Fang et al. demonstrated that PARP inhibition or genetic deletion preserves NAD+ levels and extends lifespan in mice.

CD38 Enzyme Upregulation

CD38, a NAD+-degrading enzyme expressed in immune and inflammatory cells, increases with age and chronic inflammation. Studies by Camacho-Pereira et al. (2016) showed that CD38 knockout mice maintain higher NAD+ levels and are protected from age-related NAD+ decline. Senescent cells, which accumulate with age, express high levels of CD38, creating a vicious cycle of NAD+ depletion.

Reduced Biosynthesis

The rate-limiting enzyme in the salvage pathway, NAMPT, shows decreased expression and activity with age. Yoshino et al. (2011) published data in Cell Metabolism demonstrating that declining NAMPT activity correlates with reduced NAD+ levels in aged mice, and that NMN supplementation bypasses this bottleneck.

Mitochondrial Dysfunction

Mitochondria house significant NAD+ pools and synthesize NAD+ locally. Age-related mitochondrial dysfunction impairs this synthesis capacity, creating a feedback loop where NAD+ deficiency worsens mitochondrial function, which further reduces NAD+ production.

Types of NAD+ Supplements: NMN vs NR vs Niacin

Each NAD+ precursor operates through distinct metabolic pathways with different pharmacokinetics, bioavailability profiles, and evidence bases.

Nicotinamide Mononucleotide (NMN)

NMN sits one step closer to NAD+ in the biosynthetic pathway than NR. The molecule enters cells through proposed NMN-specific transporters (Slc12a8 in mice) or via extracellular conversion to NR. Sinclair's research group has published extensively on NMN, showing improvements in glucose metabolism, mitochondrial function, and vascular health in rodent models.

A 2021 placebo-controlled human trial in Science by Igarashi et al. demonstrated that 250mg daily NMN supplementation for 10 weeks improved insulin sensitivity in prediabetic women. Products like Vita Aid NMN 300 provide pharmaceutical-grade NMN in stable, third-party tested formulations.

Typical dosing: 250-1,000mg daily, taken in the morning on an empty stomach for optimal absorption.

Nicotinamide Riboside (NR)

NR, a form of vitamin B3, converts to NAD+ through NR kinase enzymes (NRK1/NRK2). Charles Brenner's research established NR as an effective NAD+ booster, with multiple human clinical trials published. ChromaDex's Niagen brand has funded most NR human research.

A 2018 study in Nature Communications by Martens et al. showed that 1,000mg twice daily NR supplementation raised NAD+ levels approximately 60% in healthy middle-aged adults, with improvements in blood pressure and arterial stiffness. NR demonstrates excellent oral bioavailability and safety profiles across multiple trials.

Typical dosing: 300-1,000mg daily, divided into morning and afternoon doses.

Niacin (Nicotinic Acid)

Niacin, the oldest known NAD+ precursor, converts to NAD+ through the Preiss-Handler pathway. While effective at raising NAD+ levels, niacin causes vasodilation ("niacin flush") in most users due to activation of GPR109A receptors, releasing prostaglandins. This side effect limits tolerability despite niacin's low cost and proven efficacy.

Extended-release formulations reduce flushing but carry hepatotoxicity risks at high doses. Niacin also favorably modulates lipid profiles, raising HDL and lowering LDL and triglycerides, which may provide additional cardiovascular benefits distinct from NAD+ elevation.

Typical dosing: 500-2,000mg daily (immediate-release causes flushing; extended-release reduces flushing but increases liver enzyme elevation risk).

Nicotinamide (NAM)

Nicotinamide, another form of vitamin B3, enters the salvage pathway through NAMPT. However, NAM also acts as a sirtuin inhibitor at higher concentrations, potentially counteracting some benefits of NAD+ elevation. Most researchers favor NMN or NR over NAM for longevity-focused supplementation, though NAM remains useful for general B3 repletion.

Comparison Table: NAD+ Supplement Types

Supplement Type	Pathway	Bioavailability	Typical Dose	Side Effects	Human Evidence	Cost
NMN	Direct/via NR conversion	Good (oral)	250-1,000mg/day	Minimal; occasional GI upset	Limited (3 RCTs)	$$$
NR	NRK1/NRK2 pathway	Excellent (oral)	300-1,000mg/day	Minimal; well-tolerated	Strong (8+ RCTs)	$$$
Niacin	Preiss-Handler pathway	Excellent (oral)	500-2,000mg/day	Flushing, liver enzymes ↑	Extensive (decades)	$
Nicotinamide (NAM)	Salvage (NAMPT)	Excellent (oral)	500-1,000mg/day	Minimal; sirtuin inhibition	Moderate (B3 studies)	$
NAD+ IV	Direct infusion	100% (intravenous)	250-1,000mg/session	Infusion reactions, cost	Minimal (case reports)	$$$$

How to Choose the Right NAD+ Supplement

Selecting an appropriate NAD+ precursor depends on individual health status, goals, budget, and tolerance for side effects.

Consider Your Health Goals

Energy and athletic performance: NMN shows particular promise for mitochondrial ATP production and endurance. A 2021 study in Nutrients by Liao et al. found that 300mg NMN daily for 6 weeks improved aerobic capacity in recreational runners.

Cardiovascular health: NR demonstrates benefits for arterial stiffness and blood pressure. Niacin provides additional lipid benefits but with flushing side effects.

Metabolic health and insulin sensitivity: Both NMN and NR show promise. The Igarashi trial demonstrated NMN's benefits for insulin-resistant women; multiple NR trials show improvements in metabolic markers.

Neuroprotection and cognitive function: Animal studies suggest both NMN and NR cross the blood-brain barrier and support neuronal NAD+ levels, though human cognitive data remains limited.

Verify Third-Party Testing

The NAD+ supplement market contains significant quality variability. Reputable manufacturers provide:

Certificates of Analysis (CoA) verifying purity and potency
Third-party testing for heavy metals and contaminants
Pharmaceutical GMP manufacturing standards
Stability testing data

Brands available through Apotheca—including Thorne Research, Pure Encapsulations, and ProHealth Longevity—maintain these standards as a prerequisite for practitioner-grade distribution.

Assess Formulation and Stability

NMN degrades in the presence of moisture and heat. Quality formulations use moisture-barrier packaging, desiccants, and stability-tested formulas. Sublingual formulations claim enhanced absorption, though comparative bioavailability data versus capsules is limited.

NR chloride shows better stability than earlier NR forms. Look for products stored in opaque, moisture-resistant bottles.

The NAD+ Restoration Protocol

Comprehensive NAD+ restoration extends beyond single-precursor supplementation to address multiple aspects of NAD+ metabolism and cellular health. The NAD+ Restoration Protocol available through Apotheca combines evidence-based interventions:

Core NAD+ Precursor

Foundation supplementation with either NMN 300mg daily or NR 500mg daily provides the biosynthetic substrate for NAD+ elevation. Taking precursors in the morning aligns with circadian NAD+ rhythms.

CD38 Inhibition

Natural compounds that inhibit CD38 preserve NAD+ by reducing degradation. Apigenin (found in parsley and chamomile) and luteolin demonstrate CD38 inhibitory activity in vitro. Quercetin, while primarily known as an antioxidant, also shows modest CD38 inhibition.

Products like Progressive Labs Trans-Resveratrol with Quercetin combine sirtuin activation (via resveratrol) with potential CD38 inhibition.

Sirtuin Activation

Sirtuins require NAD+ as a cofactor but also deplete it during activity. Compounds that enhance sirtuin efficiency—allowing more cellular benefit per NAD+ molecule consumed—include resveratrol, pterostilbene, and fisetin. While resveratrol's direct sirtuin activation in humans remains debated, it provides antioxidant and anti-inflammatory benefits complementary to NAD+ restoration.

Autophagy Enhancement

Spermidine supplementation induces autophagy—the cellular recycling process that clears damaged proteins and organelles. Enhanced autophagy reduces cellular stress and may decrease NAD+ consumption by PARPs engaged in stress responses. Human studies show 1-2mg daily spermidine improves cardiovascular and cognitive outcomes in older adults.

Supporting Nutrients

Magnesium: Required cofactor for NAD+ biosynthetic enzymes
Vitamin B2 (riboflavin): Precursor to FAD, which works alongside NAD+ in redox reactions
Methylation support: TMG (trimethylglycine) or methylated B-vitamins support the methionine cycle linked to NAD+ metabolism

Dosing Guidelines: What the Research Suggests

Human clinical trials provide dosing frameworks, though individual optimization may require experimentation within safe ranges.

NMN Dosing

Published human trials have tested:

250mg daily: Igarashi et al. (2021) - improved insulin sensitivity in prediabetic women
300mg daily: Liao et al. (2021) - enhanced aerobic capacity in runners
1,250mg daily: Yi et al. (2023) - well-tolerated in healthy adults with NAD+ elevation

Most practitioners recommend starting with 250-500mg daily, taken in the morning 15-30 minutes before breakfast for optimal absorption. Some users report better results splitting doses (morning and midday), though comparative data is lacking.

NR Dosing

Clinical evidence supports:

300mg daily: Minimal effective dose for NAD+ elevation (Airhart et al., 2017)
500mg twice daily (1,000mg total): Martens et al. (2018) - robust NAD+ increase and cardiovascular improvements
1,000mg three times daily (3,000mg total): Well-tolerated in safety studies, though unclear if superior to lower doses

Starting with 300-500mg daily and increasing based on response represents a reasonable approach. Dividing total daily dose into morning and afternoon servings may maintain more stable NAD+ levels.

Niacin Dosing

For NAD+ elevation without severe flushing:

Start with 100mg immediate-release niacin with food
Increase by 100mg weekly as tolerance develops
Target dose: 500-1,000mg daily for NAD+ benefits
Taking aspirin (81-325mg) 30 minutes before niacin reduces flushing intensity

Extended-release niacin at doses above 2,000mg daily increases hepatotoxicity risk. Monitor liver enzymes if using high-dose niacin long-term.

Timing and Food Interactions

NMN and NR show optimal absorption on an empty stomach, though some users experience mild nausea and prefer taking with light food. Morning dosing aligns with natural circadian NAD+ rhythms, which peak in early day.

No significant drug interactions are reported for NMN or NR at standard doses. Niacin interacts with statins (increased myopathy risk) and diabetes medications (may affect blood glucose).

Stacking NAD+ Supplements for Maximum Effect

Combining NAD+ precursors with complementary compounds addresses multiple aspects of cellular aging and metabolic health.

NAD+ Precursor + Sirtuin Activator

The classic stack pairs NMN or NR with resveratrol. Sirtuins require NAD+ to function, so elevating both substrate (NAD+) and activator (resveratrol) theoretically enhances sirtuin-mediated benefits. Sinclair's lab research in mice used this combination to demonstrate lifespan extension and metabolic improvements.

A practical formulation: 500mg NMN + 500mg resveratrol (or 150mg pterostilbene, a more bioavailable resveratrol analog) in the morning with fat for resveratrol absorption.

NAD+ Precursor + CD38 Inhibitor

Preventing NAD+ degradation while increasing synthesis creates a favorable balance. Apigenin (50mg) or luteolin (100mg) taken with NAD+ precursors may preserve elevated levels, though human data is absent. Quercetin (500-1,000mg) provides broader antioxidant benefits alongside potential CD38 inhibition.

NAD+ Precursor + Autophagy Inducer

Combining NMN or NR with spermidine creates synergy between energy metabolism enhancement and cellular cleanup. Research suggests this combination may be particularly beneficial for neuroprotection and cardiovascular health.

Example stack: 500mg NMN + 1mg spermidine taken in the morning.

NAD+ Precursor + Mitochondrial Support

NAD+ supports mitochondrial function, but combining with additional mitochondrial nutrients may amplify benefits:

CoQ10 (ubiquinol): 100-200mg for electron transport chain support
PQQ: 10-20mg for mitochondrial biogenesis
L-carnitine: 500-2,000mg for fatty acid transport into mitochondria
Creatine: 5g for phosphocreatine energy buffer

Full NAD+ Restoration Stack Example

A comprehensive evidence-based protocol:

Morning (fasted):

500mg NMN
500mg resveratrol with small amount of fat
1mg spermidine
100mg ubiquinol

Afternoon:

500mg quercetin
200mg magnesium glycinate

Evening:

Methylated B-complex

This stack addresses NAD+ synthesis (NMN), sirtuin activation (resveratrol), autophagy (spermidine), mitochondrial support (ubiquinol), CD38 inhibition (quercetin), and cofactor support (magnesium, B-vitamins).

Side Effects and Safety Considerations

NAD+ precursors demonstrate favorable safety profiles in published human trials, though long-term data (>1 year) remains limited.

NMN Safety Profile

Clinical trials using up to 1,250mg daily NMN for 12 weeks report minimal adverse events. Occasional side effects include:

Mild gastrointestinal discomfort (nausea, bloating) - typically resolves with dose reduction or taking with food
Headache - rare, may relate to vasodilation effects
Insomnia or vivid dreams - anecdotally reported when taken late in the day

No serious adverse events or laboratory abnormalities have been reported in published NMN trials. Theoretical concerns about cancer risk (due to NAD+'s role in cellular proliferation) have not materialized in animal or human studies, though surveillance continues.

NR Safety Profile

NR has been tested in multiple trials at doses up to 2,000mg daily with excellent tolerability. Side effects are uncommon and mild:

Mild nausea - resolves with food intake
Flushing (rare, much less than niacin)
Fatigue - occasionally reported, mechanism unclear

Long-term safety data (6-12 months) shows no accumulation of adverse effects. Liver and kidney function markers remain stable.

Niacin Safety Profile

Niacin's safety profile is well-established through decades of clinical use for lipid management:

Common side effects:

Flushing (vasodilation, prostaglandin release) - nearly universal at doses >100mg
Pruritus (itching) accompanying flush
Gastrointestinal upset

Serious but rare concerns:

Hepatotoxicity - particularly with extended-release formulations at >2,000mg daily; monitor liver enzymes
Hyperglycemia - may worsen insulin resistance in susceptible individuals
Hyperuricemia - can precipitate gout in predisposed individuals
Myopathy - especially when combined with statins

Medical supervision is recommended for high-dose niacin (>1,000mg daily).

Contraindications and Precautions

Pregnancy and lactation: Insufficient safety data; avoid supplemental NAD+ precursors beyond standard prenatal vitamins containing B3.

Active cancer: Theoretical concern that NAD+ elevation could support tumor metabolism. While animal studies show mixed results (some cancers protected, others unaffected), prudence suggests avoiding until more data exists.

Liver disease: Use caution with high-dose niacin; NMN and NR appear safer but data is limited.

Diabetes: Monitor blood glucose when starting NAD+ precursors, as metabolic effects may alter insulin sensitivity and medication requirements.

Quality and Purity Concerns

Third-party testing is critical. Contaminant risks in unregulated supplements include:

Heavy metals (lead, cadmium, arsenic)
Microbial contamination
Underdosing or absence of claimed active ingredient
Substitution with cheaper compounds (nicotinamide instead of NMN)

Purchasing from practitioner-grade suppliers through platforms like Apotheca ensures pharmaceutical manufacturing standards and legitimate third-party verification.

Frequently Asked Questions

What is the best NAD+ supplement?

No single "best" NAD+ supplement exists; the optimal choice depends on individual factors. NR (nicotinamide riboside) has the strongest human clinical evidence with 8+ published trials demonstrating safety and NAD+ elevation. NMN (nicotinamide mononucleotide) shows promise with growing human data and sits one step closer to NAD+ biochemically. Niacin effectively raises NAD+ but causes flushing side effects. For most people seeking evidence-based NAD+ restoration, pharmaceutical-grade NR or NMN from manufacturers like Thorne, Pure Encapsulations, or ProHealth Longevity represents the best balance of efficacy, safety, and tolerability.

How long does it take for NAD+ supplements to work?

NAD+ levels rise within hours of taking NMN or NR, with peak blood levels occurring 1-3 hours post-ingestion. However, subjective benefits like improved energy, sleep quality, or mental clarity typically emerge over 1-4 weeks as cellular NAD+ pools stabilize and downstream metabolic adaptations occur. Clinical trial endpoints measuring insulin sensitivity, arterial stiffness, or exercise capacity show significant changes at 6-12 weeks. For longevity-focused interventions (mitochondrial health, DNA repair), benefits likely accumulate over months to years. Some users report noticeable energy improvements within days, while others require 4-8 weeks to perceive changes.

Can I take NMN and NR together?

While not harmful, taking NMN and NR together provides minimal additional benefit and increases cost. Both molecules convert to NAD+ through overlapping pathways, and cells have limited capacity to store excess NAD+ beyond their metabolic needs. If cells are already saturated with NAD+ from one precursor, adding another yields diminishing returns. More effective strategies involve combining a single NAD+ precursor (NMN or NR) with complementary compounds that address different aspects of NAD+ metabolism—such as CD38 inhibitors (quercetin), sirtuin activators (resveratrol), or autophagy inducers (spermidine). The NAD+ Restoration Protocol implements this multi-pathway approach.

Do NAD+ supplements really work for anti-aging?

NAD+ supplements reliably raise cellular NAD+ levels in humans, as demonstrated in multiple clinical trials. The critical question is whether this translates to meaningful anti-aging benefits. In animal models, NAD+ precursors extend healthspan, improve mitochondrial function, enhance DNA repair, and show protective effects against age-related diseases. Human trials demonstrate improvements in specific aging biomarkers—insulin sensitivity (Igarashi et al., 2021), arterial stiffness (Martens et al., 2018), and muscle function—but lack long-term data on lifespan or major disease prevention. Current evidence supports NAD+ supplementation as one component of a comprehensive longevity strategy, alongside exercise, caloric moderation, sleep optimization, and stress management. Expectations should remain calibrated to existing data: measurable metabolic improvements rather than dramatic age reversal.

What time of day should I take NAD+ supplements?

Morning dosing aligns with natural circadian rhythms of NAD+ metabolism, which peaks in early day and declines toward evening. Taking NMN or NR 15-30 minutes before breakfast on an empty stomach optimizes absorption. Some users report improved energy and alertness with morning dosing, while late-day dosing occasionally causes insomnia or vivid dreams. If splitting doses (e.g., 500mg morning + 500mg afternoon for a 1,000mg total), take the second dose before 3 PM to avoid potential sleep disruption. No definitive human studies have compared morning versus evening efficacy, so individual experimentation within this general framework is reasonable.

Are NAD+ supplements safe long-term?

Published human trials up to 12 weeks show excellent safety profiles for NMN and NR with minimal adverse events and no concerning laboratory abnormalities. However, long-term safety data (>1 year) in humans remains limited. Niacin has decades of safety data showing generally good tolerability, with hepatotoxicity risk at high doses (>2,000mg daily) and common flushing side effects. Theoretical concerns about NAD+ supporting cancer cell metabolism have not materialized in animal studies, where NAD+ precursors show neutral or protective effects on tumor development. Given current evidence, NMN and NR appear safe for long-term use in healthy adults, but ongoing monitoring of emerging research is prudent. Purchasing pharmaceutical-grade products from reputable manufacturers reduces contamination risks inherent in unregulated supplement markets.

Will NAD+ supplements give me more energy?

Many users report subjective energy improvements with NAD+ supplementation, though individual responses vary. NAD+ plays a central role in mitochondrial ATP production—the biochemical currency of cellular energy—so restoring depleted NAD+ levels theoretically enhances energy metabolism. Clinical trials show measurable improvements in exercise capacity (Liao et al., 2021) and mitochondrial markers supporting this mechanism. However, energy levels depend on multiple factors beyond NAD+ (sleep quality, thyroid function, iron status, cortisol rhythms, psychological state). NAD+ supplements work best as part of a comprehensive energy optimization strategy rather than a standalone solution. Expect gradual improvements over weeks rather than immediate stimulant-like effects. If fatigue persists despite NAD+ supplementation, evaluate for underlying medical conditions.

Should I cycle NAD+ supplements or take them continuously?

No evidence suggests cycling NAD+ precursors is necessary or beneficial. Unlike substances that cause receptor desensitization or tolerance (caffeine, certain nootropics), NAD+ biosynthetic pathways do not show diminishing response with continuous use. Published trials use continuous daily dosing without cycling. The age-related decline in NAD+ is progressive and chronic, suggesting that ongoing supplementation maintains benefits rather than cycling off allowing depletion to return. Some practitioners recommend occasional 1-2 week breaks every 3-6 months to assess baseline function and confirm continued benefit, but this represents personalized experimentation rather than evidence-based necessity. Continuous daily use appears safe and effective based on current data.

Can NAD+ supplements help with hangovers or alcohol metabolism?

NAD+ plays a biochemical role in alcohol metabolism through alcohol dehydrogenase and aldehyde dehydrogenase enzymes, which require NAD+ as a cofactor to convert ethanol → acetaldehyde → acetate. Chronic alcohol consumption depletes NAD+ levels. Some IV NAD+ clinics market hangover treatment based on this mechanism, though controlled clinical trials are absent. Oral NAD+ precursors may theoretically support alcohol metabolism and reduce hangover severity by maintaining NAD+ availability, but published evidence is lacking. Anecdotal reports are mixed. More reliable hangover prevention strategies include hydration, electrolyte replacement, limiting alcohol intake, and N-acetylcysteine (NAC) supplementation for acetaldehyde detoxification. NAD+ supplementation may offer modest support but should not be viewed as a primary hangover remedy or justification for excessive alcohol consumption.

How do NAD+ supplements compare to NAD+ IV therapy?

NAD+ IV infusions deliver the NAD+ molecule directly into bloodstream, bypassing oral absorption and achieving 100% bioavailability. However, NAD+ is rapidly degraded in blood and poorly taken up by most tissues due to its size and charge. IV NAD+ primarily benefits blood cells and vascular endothelium with limited tissue penetration. Oral NAD+ precursors (NMN, NR) are absorbed in the gut, distributed systemically, and converted to NAD+ inside cells where it functions—arguably a more physiologically relevant delivery method. IV NAD+ therapy costs $200-800 per session with minimal published clinical evidence, while oral precursors cost $30-100 monthly with multiple peer-reviewed trials supporting efficacy. Some users report acute benefits from IV NAD+ (energy boost, mental clarity), but these effects are difficult to separate from placebo, hydration, and co-administered nutrients. For regular NAD+ restoration, oral precursors offer better value and evidence support.

Conclusion: An Evidence-Based Approach to NAD+ Restoration

NAD+ supplementation represents one of the most promising interventions in longevity medicine, supported by robust preclinical data and growing human clinical evidence. While not a panacea for aging, raising NAD+ levels addresses a fundamental metabolic deficit that occurs with age and contributes to mitochondrial dysfunction, impaired DNA repair, and metabolic disease.

Choosing between NMN, NR, or niacin depends on individual priorities—NR offers the strongest human trial evidence, NMN shows promising preliminary data with theoretical advantages, and niacin provides proven efficacy at the lowest cost but with tolerability challenges. Pharmaceutical-grade products from manufacturers like Thorne Research, Pure Encapsulations, ProHealth Longevity, and Vita Aid ensure purity and potency.

The most effective approach combines NAD+ precursors with complementary interventions addressing multiple aging pathways: autophagy induction via spermidine, sirtuin activation with resveratrol and quercetin, and comprehensive lifestyle practices (exercise, caloric moderation, sleep optimization).

The NAD+ Restoration Protocol available through Apotheca's longevity collection provides a curated, evidence-based approach to implementing these strategies with practitioner-grade formulations.

As research continues, longer-term human trials will clarify optimal dosing protocols, combination strategies, and which populations benefit most from NAD+ supplementation. Current evidence supports NAD+ precursors as a reasonable component of a comprehensive longevity and healthspan optimization program.